Antagonists Of Tweak And Of Tweak Receptor And Their Use To Treat Immunological Disorders

Abstract

The present invention relates to reagents which modify the activity of TWEAK and their use as therapeutic agents for the treatment of immunological disorders.


Claims
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Aug 25, 2009
  • Application: Oct 4, 2006
    US US 54274506 A
  • Priority: Oct 4, 2006
    US US 54274506 A
  • Priority: Aug 11, 2004
    US US 91614104 A
  • Priority: Jul 13, 2001
    US US 90581001 A
  • Priority: Jan 14, 2000
    US US 0001044 W
  • Priority: Jan 15, 1999
    US US 11616899 P

Download Citation


Sign in to the Lens

Feedback